Pyxis Oncology, Inc.

Historical 13F Holders

Symbol
PYXS
CUSIP
747324101
All holders as of
Q3 2026
Type
Equity
Class
COMMON STOCK
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 747324101 since 12/18/2024, largest first.

Filer % of Class Filed
GordonMD Global Investments LP 13G/A
16.4% 10/9/2026
Event 10/1/2026
Sullivan Lara 13D/A 11.2% 4/2/2025
Event 3/31/2025
Biotechnology Value Fund L P 13G/A
10.0% 11/16/2026
Event 9/30/2026
RTW Investments, LP 13G
9.9% 11/16/2026
Event 9/30/2026
Coastlands Capital LP 13G
5.4% 10/5/2026
Event 10/1/2026
Laurion Capital Management LP 13G/A
5.2% 11/3/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
Integrated Core Strategies (US) LLC 13G/A
4.0% 5/6/2025
Event 3/31/2025
OrbiMed Advisors LLC 13G
3.6% 11/16/2026
Event 9/30/2026
BlackRock, Inc. 13G/A 1.5% 7/17/2025
Event 6/30/2025
Millennium Management LLC 13G/A
1.3% 10/14/2025
Event 9/30/2025
Ridgeback Capital Investments L.P. 13G/A
0.6% 2/14/2025
Event 12/31/2024
Deep Track Capital, LP 13G/A
0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 105 79.8 M $190M
2026 Q2 79 34.2 M $101M
2026 Q1 78 27.6 M $40.5M
2025 Q4 79 30.2 M $34.7M
2025 Q3 73 26.8 M $59.7M
2025 Q2 75 27.5 M $30.2M
2025 Q1 92 30.3 M $29.6M
2024 Q4 102 31.6 M $49.2M
2024 Q3 93 27.9 M $103M
2024 Q2 82 28.1 M $93.1M
2024 Q1 73 23.0 M $97.8M
2023 Q4 52 8.80 M $15.8M
2023 Q3 55 7.81 M $15.4M
2023 Q2 49 9.61 M $24.6M
2023 Q1 48 10.4 M $41.5M
2022 Q4 32 19.8 M $26.5M
2022 Q3 39 19.4 M $38.3M
2022 Q2 40 20.0 M $47.7M
2022 Q1 46 18.9 M $76.1M
2021 Q4 52 18.3 M $200M